Ladies and gentlemen, good day and welcome to Emami Limited Q3 FY 2025 earnings conference call hosted by IIFL Capital Services Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during a conference call, please signal an operator by pressing the star, then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Percy Panthaki from IIFL Capital Services Limited. Thank you, and over to you, sir.
Hi, good evening, everyone. I'm delighted to host the management of Emami Limited on the Q3 FY 2025 call. I have with me Mr. Mohan Goenka, Whole-Time Director and Vice Chairman. Mr. Vivek Dhir, CEO, International Business. Mr. Gulraj Bhatia, President, Healthcare Division. Mr. Rajesh Sharma, President, Finance and IR. And Giriraj Bagri, Chief Growth Officer. Over to you, sir, for your results presentation.
Thank you, Percy. A very good afternoon, ladies and gentlemen. Thank you for taking the time to join us today for our earnings call for the third quarter and nine months ended 31st December 2024. The macroeconomic environment presented a mixed bag of challenges and opportunities this quarter. Urban demand remained subdued. Sorry, just a second. The urban demand remained subdued, impacted by rising food inflation and cash-strapped retail and wholesale trade. However, rural demand demonstrated resilience, supported by favorable monsoons and a good harvest. That said, delayed winters hurt seasonal categories, further adding to the complexities of the market dynamics. Despite these headwinds, I am pleased to share that we achieved a robust growth of 8.6% in our core domestic business, with volume growth of around 6%. This marks the second quarter of this financial year where our core domestic business has grown in high single digits.
This is after absorbing challenges in male grooming and Kesh King, which declined by 4% and 10% during the quarter. BoroPlus range demonstrated remarkable resilience, growing by 20% despite delayed and mild winters, primarily driven by strong performance of antiseptic cream. Our healthcare range delivered robust growth of 13%, led by 90% growth in Zandu Care, while both Navratna and pain management portfolios grew by 3% each. After absorbing the decline in revenues by 13% in strategic investments and 3% in international business, our overall consolidated revenues for Q3 stood at INR 1,049 crores, with a growth of 5% in Q3. As you would be aware, a significant milestone was the rebranding of Fair and Handsome to Smart and Handsome this month. The new identity will cater to a wider portfolio, emphasizing the brand's holistic approach to male grooming, offering effective solutions for face, body, and hair care.
We see a tremendous opportunity to address a broader spectrum of male grooming needs for today's dynamic young men. The rebranding is a strategic decision driven by consumer insights that highlight a shift towards individuality, diversity, and confidence, focusing on natural skin health among today's young men. With exciting new product launches on the horizon and Karthik Aaryan as the new face of the brand, we are confident that this refreshed identity of Smart and Handsome as a comprehensive grooming solution will further solidify our leadership in the evolving male grooming market. We also launched Mentho Plus Balm Total in the southern region in December 2024, positioned as an aromatic balm addressing all types of body pain, leveraging the equity of Mentho Plus Pain Balm in the southern region.
On the distribution front, our organized channels continued to strengthen with modern trade, e-commerce, and institutional sales, now contributing to 28.6% of domestic business, an increase of 160 basis points in Q3. These channels grew at nearly double the pace compared to overall business. Importantly, this quarter, we continue to deliver profit-led growth with improved margins across the board. Our gross margins expanded by 150 basis points to 70.3%. EBITDA grew by 8% to INR 339 crores, with margins expanding by 70 basis points, and profit after tax also increased by 8% to INR 279 crores. In nine months ended December 2024, gross margins expanded by 140 basis points to 69.6%. EBITDA grew by 9% to INR 806 crores, and PAT increased by 12% to INR 644 crores. I'm pleased to inform that the board of directors have approved a second interim dividend of 400%, translating to INR 4 equity shares for FY 2024.
This follows the first interim dividend of 400%, also amounting to INR 4 per share declared in Q2. Cumulatively, we have distributed dividends of 800%, equivalent to INR 8 per share during FY 2024, reaffirming our commitment to maximizing shareholders' return and aligning our dividend payout policy. To sum up, FY 2025 has been a positive year till now, with our core domestic business delivering 7% growth, including 5% volume growth for the nine months ended December 2024. We are confident of closing the financial year on a high note, looking ahead, improving macroeconomic indicators, and a sequential revival in demand signals, a positive outlook for the FMCG sector. With the successful rebranding of Smart and Handsome, focused intervention for Kesh King, and the anticipated turnaround in our international business, we are well positioned for robust growth in the coming periods.
Our unwavering commitment remains towards driving superior performance across all business segments, expanding market shares, and creating sustained value through strategic brand building, profitable growth, and long-term value creation. With this, I would now like to open the floor for questions. Thank you.
Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on their touch-tone telephone. If you wish to remove yourself from the question queue, you may press star and two. Participants are requested to use handset while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. The first question is from the line of Abneesh Roy from Nuvama. Please go ahead.
Yeah, thanks, and congrats on good volume growth and overall momentum. My first question is on the two segments which have done well this quarter. One is BoroPlus 20% growth and healthcare 13% growth. That's a good number in the current slowdown and late winter also. So is it because of some base effect which is favorable, or you have really seen market share expansion or the new product launches which are doing well? And would you say that this is something which can sustain even in Q4 because winter is still there, and definitely that should further help because it's a harsh winter, but then it becomes a bit late also in Q4 given when winter will withdraw? So how do you see Q4 for these two businesses?
So Avneesh, yes, BoroPlus growth has been led by the core antiseptic cream, okay, where we have grown phenomenally in double digits, more than 20%. So yes, I would say the base was also low, but even though, even at a lower base, the growth of 20% was really exciting. Yes, this momentum continues in this quarter also, it looks like, because this month BoroPlus has done exceedingly well. Okay. So same is for healthcare. Healthcare is also for the last few quarters, we are continuously giving double-digit growth, which is led by Zandu Care. And this quarter also, we expected double-digit growth in both BoroPlus and healthcare. So overall, yes, I think despite of challenges, which I said in my opening remark, overall, some of the brands have done exceedingly well, and we see a good momentum also in this quarter.
Sir, and last question will be on The Man Company. So where do you see the recovery happening? I do understand overall market, there is a challenge, but what are the steps needed here? Will it be more of a base effect when that normalizes, then the growth will come, or something can be done before the base effect helps you? Could you talk about that?
So, Avneesh, we have also this time Giriraj Bagri, who is our Chief Growth Officer. He drives all the new startups and new ventures, The Man Company, Brillare, all these, so he is also on the call. Giriraj, you are there on the call, right?
Yes.
Yeah. So Giriraj, you can take this on The Man Company. He drives all these strategic initiatives, yeah.
Yeah. Abneesh, thanks for your question, and glad to be on this call. As far as The Man Company is concerned, we are seeing a sequential month-on-month improvement in performance, and going forward in quarter four, we expect quarter four to be significantly better than quarter three.
But what exactly were the challenges? Was it just a discounting by peers, which you have mentioned in the presentation, for example? So is it just because overall urban slowdown is there, that's the reason, or there was some inventory pile-up which you had, which is also driving this?
There are two or three factors. One factor, obviously, last year, if you remember, we had festivities over two months. This time, we had festivities over one month, and therefore, all the activities of major platforms were compressed into one month. The second factor is that we have moved a lot of the businesses moving to quick commerce, and we have also started moving to quick commerce. We were a little delayed in our shift to quick commerce, but we have caught up with the rest of the market by the end of the quarter. That is the second piece that we see. And obviously, the overall urban consumption, as everybody has been mentioning, has marginally impacted us, but we are seeing a significant turnaround on that at this point in time.
Understood. That's all from my side. Thank you.
And transition also happened, Abneesh. So transition also impacted some bit of it. But now it is in full control. Giriraj has taken full control. Hopefully, things should improve from this quarter.
Okay. Thank you.
Yeah. Thank you. The next question is from the line of Harit Kapoor from Investec. Please go ahead.
Yeah, hi, good evening. So just two questions. One was on Kesh King. Mohan, I just wanted to get a sense of what changes now you're kind of looking to make in that brand, and if any, and when do we start to see that play out in the market?
So Harit, we have continuously been mentioning that BCG is on it, okay? You have seen a big change. Fair and Handsome was also not going for some quarters, but we did a significant change in Fair and Handsome, right? Similarly, Kesh King is being evaluated by BCG. Let them come up with a robust strategy. Once they come up with that and we start implementing, I'm sure the brand should revive. It's not over. I think it will take another one or two quarters, but then surely we'll come with the bang.
Got it. Just one question on that. Do you think it's also a category issue, or you think it's more internal, which you can solve through the BCG changes?
No, definitely category issue is there. In the oil we are seeing, it's not just Kesh King. All the other oils are also slowed down. So see, but we can't wait for markets to, of course, market is one thing. If they revive, we will get extra benefit, okay? But whatever changes that need to be done are for the brand. Opportunities in shampoo and other hair care, there are multiple opportunities which have been identified. So as I said, a lot of working is going on. So hopefully, in the next one or two quarters, we will see something.
Great. Great. And on Smart and Handsome, so if you could just give a sense of from going from skincare to overall male grooming, when do we kind of expect this entire rollout in the market? Have we already put it in the market, old stocks out, new stocks in? Just could you give us a timeline of how we look at it from the next quarter or two?
Yeah. So no, the transition has happened for the base cream and face wash. So it started about a month back, and now the product that you will see in the market is all Smart and Handsome. In fact, the new advertising has also started from 15th of January for Smart and Handsome, okay? And as far as the extensions or the entire male grooming range is concerned, that will start rolling out in the next three to four months.
Understood. Any changes on the pricing standpoint or pricing part as well, or I mean, you maintain similar kind of pricing structures for the new launch?
We haven't changed the prices.
Got it. Got it. And lastly, Mohan, just on this rural versus urban kind of a mix, could you just give us a sense of what is the kind of differential in rural versus urban for you in terms of growth over the last quarter or couple of quarters, or however you want to kind of quantify that? Just wanted to get a sense of how much faster is kind of rural growing for you, if you could just help us understand that.
So Harit, BoroPlus is a mass brand, okay? And the growth that BoroPlus has grown at 20%, of course, it is driven by the rural growth, okay? And as I said, this month also, we are seeing good growth coming in for BoroPlus and some of the other brands also. Also, Smart and Handsome has revived because of the new launch. So we are seeing, I would say that at least for us, there has been an improvement in the rural growth. I can only say that.
Got it. I'll come back to Mohan. Thank you very much.
Thank you. Ladies and gentlemen, if you wish to ask a question to the management, you may press star and one. The next question is from the line of Percy from IIFL Capital Services. Please go ahead.
Yeah. Hi. I just wanted to understand the drivers behind the gross margin expansion, given that there has been no commodity deflation. Is it a mixed effect, or have you taken pricing in some of the products? What is the story behind this?
Yeah, Percy. So both the price hikes which we have taken or the realization improvement which we have seen during the quarter, and also lower input prices on some of the areas, and some of the cost reduction initiatives which we have taken, so all these put together has helped us to get this margin expansion on the gross margin front.
Understood. Just to follow up on that, the pricing that you have taken, is it in some specific categories? And secondly, you mentioned input cost deflation in a couple of inputs. So which are those inputs where we have seen a deflation?
We have seen some on the packaging material mostly. And also, the pricing is mostly across. So not on the LUPs, but on the larger pack, some bit of pricing on an average 1.5%-2.5% kind of pricing benefit is there.
Understood. Understood. Secondly, on Kesh King, we have already, I think, put some initiatives in place to improve the growth. Is there anything still in the pipeline which is pending in terms of initiatives? I understand you might not be able to say what they are because it's competitive in nature, but just wanted to understand if there is anything sort of pending in terms of actions from our side, or whatever we had to do, we have already sort of put in.
So Percy, as I said, we will have to wait for the strategy to be firmed up, then only we can throw some light, okay? Because the category size is huge, opportunity is huge, okay? And oil is just one category in the Kesh King. The shampoo is another. Plus, there are many other categories that we can get into, okay, under this brand. So that has been worked upon. You will have to wait for another four or five months for us to get back. Sure. Sure. We can move on to the questions.
But I can only say a lot of work is going on.
Understood. Understood. Steve, we can move on.
Thank you. The next question is from the line of Tanay from Investec. Please go ahead.
Yeah. Hi. Just wanted you to shed some light on the international business. I'm looking at new products. What is the reason behind the growth of the product? And just an environment perspective, if you could tell us a bit more.
Vivek?
Good afternoon. International business, we couldn't do much in Russia with the very high interest involvement over there, and that is the prime reason when you look at the quarter. We had a massive decline in that particular geography, but cumulatively for the nine months, still, Russia has delivered double-digit growth, so that is one area where we had underperformed in this quarter. The Russia-Ukraine business in this particular quarter goes up significantly as a contribution to the overall business, and that is where the hurt has been. So Bangladesh by and large has been under control, and many of the markets have been under control. So this area, due to high interest rate involvement, we couldn't extend big credits into the market. It's usually a break. Usually, that market operates between 60-120 days over there.
Got it. And how are we looking at this going ahead? Are you looking at expanding products in these segments?
Product expansion is happening with respect to different geographies so we could manage to extend certain tentacles in Africa, especially in the East Africa region. GCC, MENA region, we continue to expand in portfolios of BoroPlus in skincare. Most of them are doing well for us. Bangladesh, we attempted to expand our leading brand, which is 7 Oils, into shampoos as well over there. A little bit of, I think, mixed response. Certain pockets of success, certain pockets we couldn't do much so shampoos in Bangladesh. The bottles we have clearly fared well over there so it's a mixed response in Bangladesh and the political instability in Bangladesh, also, we have gone through in launches and investments over there. We also are very conservative as a business. We were conservative in extending any credit. We all operate on cash in that market. So after national distribution, the market is purely on the cash basis. So that is how we are operating. Still, we have been managed to deliver some growth in Bangladesh in this quarter.
Got it. Got it. Thank you. But you would see some revival, Tanay, I think.
Yeah. Also, it's almost in the last five years, 20 quarters, is one bad quarter due to very bad performance in Russia. We have not been able to deliver the growth. But when we look at 20 quarters, we would have decent. And we'll see a good revival in quarter four again. We should have good revival in quarter four. That's more of an aberration which is happening. Thank you.
The next question is from the line of Ajay Thakur from Anand Rathi Securities. Please go ahead.
Hi. Thanks for taking my question. So I wanted to understand a bit more on the price increases. For the quarter, I believe we have about 1% kind of a price increase. So the price increases which had been taken wouldn't have been reflected in the price increases which were there for the quarter. Will that be kind of a right assumption, or how is it?
Yes. Yes, Ajay. So there have been some price increases which have happened, which if the sales have happened in this quarter, it has come in this quarter, right? So not that every product price goes up at one time. Some SKUs in some products, prices, it's over a period. So some benefit has come in these quarters. About 1%.
Understood. So what kind of weighted average price increase can we factor for the coming quarter is what I was trying to understand.
It would be in the range of, yeah, 1.5%-2%.
Okay. Thanks. Secondly, wanted to also understand a bit more on the tax rate. What would be the projected tax rate for the current year and for the year going ahead for FY 2026?
So just for FY 2025, I think the current trajectory should be there around 8%-9% kind of tax rate. And going ahead for next year also, it should be within the range of 10% kind of.
Understood. Thanks. Thanks. That's it for my two questions. Thank you.
Thank you. The next question is from the line of Shirish Pardeshi from Motilal Oswal. Please go ahead.
Yeah. Hi. Good evening, Mohanji, Rajeshji. Thanks for the opportunity. Just one broad question. When we look back, most of the FMCG companies, staples companies are struggling managing the channel conflict, whether it is quick commerce, modern trade, e-commerce. So I just wanted to understand. You have given me a number at 28% contribution, but if you can specify how this channel looks like, the growth, the individual growth, and how are you managing this conflict? Of course, we have been beneficiary because we have a very seasonality-led consumption. But I'm just more interested in how you look at it.
So Suresh, definitely the channel conflict is not easy to manage because it still exists. But these are emerging channels, so presence is almost mandatory. Of course, there are different SKUs for different channels. For rural, it's driven by sachets in modern trade, e-com, quick commerce. It is, of course, driven by large packs. And for GT, it is driven by mid packs. So this is one way of managing the conflicts. But still, there are some packs which also go in GT and MT e-com. So there the conflict is a little higher. We're trying to solve it, but we have solved quite a bit. That's why we see these growths coming in these channels. So the only way is segregating the packs for individual channels so you can minimize the conflict.
Just one observation. I mean, if I believe what you said, the small packs have done better. But still, you have shown a good improvement in the gross margin. So is the broad SKU mixes remain stable, standard, or it is still tilted towards large pack?
No. See, the margins have also increased due to the mix because BoroPlus Antiseptic Cream, the growth has been significantly higher, which is a high-margin product. Okay. So due to that, we are seeing significantly high growth in margins.
Okay. My next question is to Giri. Giri, hi. Speaking to you after many years. On the Man Company, can you tell me how the distribution takes place today after it changed hands from the promoters? And which other channels look promising? I mean, yes, we know the modern trade is a bigger opportunity and e-commerce is doing well. But how are you trying to manage the large accounts, say, A-class outlets?
Hi, Suresh. Good talking to you after a while. So as far as the Man Company is concerned, at this point in time, it still remains a dominant online play. We don't have so much of an offline exposure as many of the other brands might have, though we are present in GTs and certainly few modern trade accounts. And fundamentally, the way we look at it is that our share of the entire male grooming business is in low single digits at this point in time as far as TMC is concerned. So from across the channel, I think we have a very significant headroom for growth as far as future is concerned. Now that the transition in the management is complete, and we are now trying to drive the whole business much more aggressively than in the transition phase, so I think we should see a very broad-based recovery as far as TMC is concerned.
Giriraj, I'm asking this question from the context about two quarters before when we changed the hand. There was an inventory and an issue. I hope that is behind. So my question is that how much TT contribution over the next one year we can see?
Currently, the broad split in the business is roughly around about 75% is online, 25% is offline, and offline is all channels put together, including CSD, EBO, and then you have modern trade, institutional channels, all of that. I think the ratio will probably be broadly similar as far as the few quarters down the line is concerned. In the longer horizon, obviously, as we start moving into more of traditional trade, then you may see a mix changing a little more in favor of traditional trade than in terms of new channels.
Okay. Okay. But inventory should not be an issue going forward. That's what you're confirming?
Yeah.
Is it normalized now?
Yes. Inventory is normalized.
Okay. Last question. Vivek Dhir, congratulations. Good number. Can you share how this growth has happened, maybe subsegments like Zandu, Devantaraj, Lucis Healthcare, maybe Pancharishta? What are the growth rates you have achieved?
Hello, Mr. Shirish. How are you?
Good. Good.
Across the board, whether it is hair juices, cough syrup, and Vigorex, we've had strong growth, including in our generic and ethical medical business. We had good growth across many of the brands in high double digits. The only challenge has been so far on Pancharishta, where we had a challenge in terms of the growth, basically. We are trying to address this issue by way of looking at some new campaigns, both digitally and offline in terms of regular ATL. We are also looking at modernizing the packaging and making it more contemporary, more scientific. Besides Pancharishta, all other brands have or all other categories have done well for us, including 7 Oils.
Last year, Pancharishta, or maybe after COVID, Pancharishta was a hero product for us. But can you share a little more thoughts? Is the profile of the customers has changed, and that's why we are struggling, or is it that the change, new modern look, something has to be done?
I think it's a mix of everything, so as you said, during COVID, we had seen very strong growth for the brand, and post-COVID, there has been a decline. I think so there is the factor of the higher base of COVID, but it's been now a couple of years after COVID. From what I've understood of the industry per se, and I'm not just talking Pancharishta, this format, which is called as Arishta or Asava, has spread across companies, so this whole format is seeing a bit of a pressure in terms of volume growth across organizations, across categories. We also know that some other companies which have large brands in this format are also struggling, so like you said, there is a sudden challenge which we may be seeing from a consumer perspective in terms of the more modern, the more minimal consumers not wanting to accept it. We are trying to address this issue also from a packaging and other perspective.
Okay. Thank you. Thank you, Mohan G. All the best.
Thank you, Shirish. The next question is from the line of Kunal Vora from BNP Paribas. Please go ahead.
Yeah. Thanks for the opportunity. I just wanted to understand the base this time. We were soft this quarter, but in the next two quarters, we have a high base due to good winter and good summer.
Hey, Kunal, sorry, your voice is not very clear. Can you?
Okay. Yeah.
Is it good?
The current participant has been disconnected. We will move on to the next question. It's from the line of Karthik Kashyap from Equirus Securities. Please go ahead.
Hi. Thank you for the opportunity. I wanted to understand with the recent acquisition of Sesa by Dabur to strengthen their Ayurvedic hair portfolio, hair oil portfolio. Do you see any impact on Kesh King?
Sorry, impact on Kesh King from where, Karthik?
Like Dabur recently acquired Sesa to strengthen their Ayurvedic hair oil portfolio, so I just wanted to understand how do you see that?
No, we haven't seen any impact of that as yet. The Kesh King category was not going for some quarters. It had to do with the category itself, not just Kesh King category, but the entire oil categories. Okay. So we don't see a big threat from that.
Okay. All right. Yes. Thank you.
Thank you. The next question is from the line of Vishal Gutka from HDFC Securities. Please go ahead.
Yeah. I think, congrats on a good set of numbers. Two questions from one side. On BoroPlus portfolio, sir, what exactly you have done that has led to this kind of growth despite winter being delayed? Definitely, you've changed the packaging. Product quality might have gone up by notches ahead. And distribution increase might have been done. If you can broadly elaborate what you have done that has led to this kind of growth. And second question on the ethical portfolio. As per my understanding, from 1st April 2024, insurance policies have started covering Ayurvedic medicines. So in that context, what are we doing to improve the salience of ethical portfolio? Thank you.
Gul Raj, you can answer for the ethical portfolio.
Sure, sir. So as you rightly said, there has been this move towards covering Ayurvedic prescription insurance policies. So this obviously benefits inpatient departments in the Ayurvedic hospitals. We have, generally over the last one and a half years, tried to improve our presence and coverage in Ayurvedic hospitals. So especially in the larger hospitals, we have more regular visits. We are doing more detailing. We are covering more doctors. And we've not seen much of a direct impact by way of the change in the policies in terms of our business volumes. And it's a bit difficult to quantify that also. But as we gradually move forward, as the industry accepts it and consumers and patients accept it, we definitely see some upsurge, these patients getting admitted to Ayurvedic hospitals. Thereby, not only ethical, but even the generic portfolio will benefit because a large chunk of the treatment also involves the generic products. That will be a gradual process. We may not see a dramatic or a sea change happening in the short term.
Got it. For the industry, for the category as a whole.
Vishal, as far as BoroPlus is concerned, this was, of course, I will not say that the season was too bad for us because 20% growth can only happen if there is a good season. So this time, whatever the season was, it was good, the dry winter, I would say. And we were also aggressive in terms of advertising and some very, very focused approach we took in some key states. So that also helped BoroPlus Antiseptic Cream to grow in rural markets. We also changed our trade scheme approach this year. So that also helped some bit of it. So it was a combination of good, dry skin and very aggressive, focused approach in certain markets and a change in our trade scheme.
Got it. Got it. Thank you, sir. I'm wishing you all the best for future quarters.
Thank you. Thank you. The next question is from the line of Nitin Gupta from Emkay Global. Please go ahead.
Hi. Thanks for the opportunity. I just want to know, what is the salience of rural now, given that we generate 29% from organized channel?
So, salience of, sorry, rural, is it?
Yeah, rural in domestic business.
Yeah, so rural would still be, if you exclude that, if you take the overall business, it should still be about 53%-54% of the domestic business.
So 53% is rural and 29% organized channel, and the rest will be general trade, urban. And when we call out 29% organized channel, do we include CSD in this?
Yes, we include the institution, yeah.
In any sense, how much CSD would be now for us?
Around 4%.
Okay. Okay. And second question is with respect to your opening remarks, and you have highlighted in urban, there is a cash trap in retail and wholesale. Can you throw some light into this?
So see, that has been there since COVID. Okay. When the demand cycle is poor, then, of course, you have to extend a little more credit to the trade. So that trend has still been continuing.
This also has an effect in terms of when we are doing the trade promotion. Incrementally, does the trade promotion look difficult?
No. So trade promotion is different. It all depends on the focus what you have, and it depends on the demand for the product. But.
Okay. Thank you.
Hi.
It's about significant change any other time.
Sure.
And my last question is with respect to Smart and Handsome and HE brand. So last quarter, we have expanded HE brand offering. And now with the name change, so how we want to position both the brands? Will Smart and Handsome focus only on the facial, and HE will look after the other male grooming?
Smart and Handsome is a widely distributed product. It's a mass product. It is available in almost 15 lakh outlets. Okay. The distribution channels are very different. Okay. And so any product that will come under Smart and Handsome will be mass priced. So price.
Yeah. Understood. In terms of category presence, I was basically wanted to gauge. Will it be facial, or you will look to extend this to other?
We will extend it to many different categories.
Okay. So HE will be the premium end, and Smart and Handsome will be most of the mass product offerings in the similar categories.
The pricing would be different, yeah.
Sure. Sure. Thank you, sir. Yeah. Thanks a lot, sir. Thank you.
The next question is from the line of Rahul Agarwal from Ikigai Asset Management. Please go ahead.
Yeah. Hi. Good evening. Thank you for the opportunity. Sir, one question was the press release talks about liquidity constraints in retail and wholesale trade channels. Just wanted to get a sense, what has been your experience in the quarter in terms of the channel behavior? Does that mean that the channel filling was actually lower than what it should be, so the growth could have been better? And secondly, second part of the question is, how will this ease out? Do you think this eases out in three to four months, and then it helps growth ahead? That's the first question.
Sorry, what was the second question, Rahul?
When does this ease out? Do you think there is a timeline to this, or do you think it's a general problem?
No, no. As I said, Rahul, this is a problem which has been going on since many, many, many quarters. It's not a new problem. Maybe we've just highlighted it in our con call. Okay. So that's why the credit cycles and everything has been consistent since the COVID. So at times, depending on your strategy, we may increase a little bit, or we are not seeing a room where we are able to decrease it. That's the only thing.
Okay. So.
Credit cycles are very consistent, and at times, you may have to increase it. That's it. I don't know when it will improve. I have no idea.
Got it. Got it. So just to quantify this, maybe Rajesh, you can help. As of December balance sheet, what is the receivable cycle right now?
So Rahul, our receivables would be roughly around 16-17 days, which is slightly improved from the last year period or March quarter. But still, that's what Mohanji said is continuing for quite some time now post-COVID.
Got it. And could you help me with the operating cash flow number for nine months, if that's possible? Thank you. That's my last question.
So if you look at our nine months, profit is almost EBITDA is almost INR 800 crores plus, and profit after tax would be INR 640 crores. So there is not significant CapEx till December. So I think around INR 500-550 crores kind of would be the operating cash flows.
Got it, sir. No, I was asking was because of tax adjustment. But I get the answer. Thank you so much. All the best.
Thank you. Thank you.
The next question is from the line of Kunal Vora from BNP Paribas. Please go ahead.
Yeah. Thanks. Am I audible now?
Yes, yes. Please.
Good. So you had a tough quarter. The next two quarters, you had a tougher base with delayed winter last time and harsh summer. So do you believe this growth trajectory which you have right now could be maintained or even improved?
So Kunal, see, as I said, we have started with a good note. I don't know how the summer will pan out to be. You are right. We have a good high base for summer products. We will have to wait and watch. But there is significant aggression in terms of new launches in distribution mixes, so SKU launches. So we will have to see. We can't be bearish all the time. If the market improves, of course, it will benefit us. But the brands, I feel most of the brands are under solid ground, other than Kesh King maybe. But hopefully, we should do better than what we have done in this quarter. That is my expectation, at least.
And second one is, what is the outlook for urban GT now? Because that number seems to be fairly small now, below 20% for you. Is it still viable via distributors, or are you having any issues retaining distributors? How is the outlook of urban GT from here, especially as e-commerce and quick commerce continues to rise?
No, there is no challenge at all as far as retaining the distributors. So. Sorry. Are you expecting anything else?
No, no. I was expecting a reported outlook. I mean, do you think it will grow or it will shrink? What happens in the next two to three years for urban GT?
No, sir. See, the channel, of course, does not change. The distribution does not change much. Channels may be changing. We may add some basket to our existing distributors, even to cover modern trade or e-commerce to make them viable. But nothing significantly changes.
I mean, servicing the retail outlets is still viable because their sales will keep on shrinking, and the kirana sales could shrink. So is it still viable to service the retailers or directly support retailers?
Of course, it's viable to serve the retailers. Your business size is also increasing. Yeah.
Understood. Okay. And lastly, bookkeeping questions. Goodwill amortization, what should be the number for FY 2026 and 2027?
Amortization.
Yeah. So for next year also, roughly INR 90 crores kind of amortization would be there, Kunal.
Okay. Okay. That's it from me. Thank you.
Thank you.
Thank you. As there are no further questions from the participants, I now hand the conference over to the management for their closing comments.
Thank you all. Thank you all for joining our Q3 conference call. And thank you, IIFL. Thank you, Percy, for arranging this for us. Good day.
Thank you.
On behalf of IIFL Capital Services Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines. Thank you.